Ugandan pharmaceutical company Dei BioPharma has filed a patent application in the United States for a new Ebola vaccine platform designed to protect against multiple strains of the deadly virus, a development the company says could strengthen Africa’s ability to respond faster and more independently when outbreaks hit. The filing, submitted to the U.S. Patent and Trademark Office, covers a …
Read More »Tag Archives: patent
Dr. Magoola’s Dei BioPharma make U.S. patent application for global ebola vaccine platform
Dr. Mathias Magoola – New mRNA innovation targets major outbreak-causing ebolaviruses, including Zaire, Sudan, Bundibugyo and the West African/Makona lineage KAMPALA, Uganda — Dei BioPharma has announced the submission of a utility patent application to the United States Patent and Trademark Office for a next-generation mRNA vaccine platform designed to provide broad protection against the world’s most dangerous Ebola-causing viruses. × …
Read More »
pressug.com News 24 7